HQY

$79.40

Post-MarketAs of Mar 17, 8:00 PM UTC

HealthEquity, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$79.40
Potential Downside
45.6%
Whystock Fair Value$43.17
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It provides health savings accounts; investment platform; and online-only automated investment advisory services through Advisor, a Web...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.87B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
36.42
Beta
Defensive asset. Lower volatility than the S&P 500.
0.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
9.01%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.49

Recent News

Associated Press Finance
Mar 17, 2026

HealthEquity: Fiscal Q4 Earnings Snapshot

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 89 cents per share. The provider of services for managing health care accounts posted revenue of $334.6 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $332.8 million.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 15, 2026

Assessing HealthEquity (HQY) Valuation As Fiscal Q4 Earnings Approach

HealthEquity earnings in focus HealthEquity (HQY) heads into its upcoming fiscal Q4 report with investors watching whether the company can again exceed expectations, as analysts look for strong EPS growth alongside more moderate revenue gains. See our latest analysis for HealthEquity. At a share price of US$77.81, HealthEquity has a 30 day share price return of 5.32% but a year to date share price decline of 14.56%, alongside a 1 year total shareholder return decline of 20.12% and a 3 year...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Insights Into HealthEquity (HQY) Q4: Wall Street Projections for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for HealthEquity (HQY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2026.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketWatch
Feb 28, 2026

These fintech stocks are loved by analysts and could bounce back in a big way

Shares of PayPal and Block are both cheap relative to historic levels, but only one of them commands heavy enthusiasm from analysts.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 27, 2026

BrightSpring Health Services, Inc. (BTSG) Q4 Earnings Lag Estimates

BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of -1.49% and +5.85%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.